MacroGenics (MGNX) PT Lowered to $32 at Wedbush, Following Clinical Business Update

June 16, 2021 1:44 PM EDT
Get Alerts MGNX Hot Sheet
Price: $20.68 +4.76%

Rating Summary:
    17 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 10 | New: 35
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten lowered the price target on MacroGenics (NASDAQ: MGNX) to $32.00 (from $34.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change